EMA Committee Recommends Approval for Injectable Version Of Merck’s Keytruda
The European Medicines Agency's committee has recommended approval for a new formulation of Merck's blockbuster cancer therapy Keytruda that can ...
The European Medicines Agency's committee has recommended approval for a new formulation of Merck's blockbuster cancer therapy Keytruda that can ...
In women with type 2 diabetes, transdermal HRT was associated with reduced ischemic heart disease risk and oral HRT was ...
Quantinuum’s quantum computerQuantinuum What can quantum computers do that their traditional counterparts absolutely cannot? This is one of the biggest ...
The skeletal muscle relaxants baclofen and tizanidine are each linked to a higher risk for injury than cyclobenzaprine in older ...
Medscape News UK Source link : https://www.medscape.com/viewarticle/one-three-licensed-gps-work-outside-nhs-2025a1000ovm?src=rss Author : Publish date : 2025-09-19 08:27:00 Copyright for syndicated content belongs to ...
According to a real-world study, naltrexone-bupropion, even at submaximal doses, is as effective for patients facing postbariatric surgery weight regain ...
Patients with potentially blinding retinitis pigmentosa recover retinal sensitivity 3 years after receiving a gene therapy targeting the causal mutation. ...
Ruxolitinib is the first topical JAK inhibitor approved in the US for pediatric AD. Medscape Medical News Source link : ...
Nat WrightHealth ProducerGetty ImagesThe Medical Practitioners Tribunal Service (MPTS) stands accused of failing victims and compounding their trauma.Sanctions for doctors ...
(MedPage Today) -- Members of the CDC's Advisory Committee on Immunization Practices (ACIP) voted 8-to-3 with one abstention for updating ...
(MedPage Today) -- The effects of the JAK inhibitor baricitinib (Olumiant) waned after treatment was stopped among patients with new-onset ...
Real-world study results provide further evidence that GLP-1 receptor agonists lower cardiovascular risk in people with psoriasis and may even ...
(MedPage Today) -- WASHINGTON -- For the first time, HHS is taking steps to decertify an organ procurement organization (OPO), ...
Lilly’s cardiovascular outcomes trial is the first to use an active comparator, finding noninferiority but not superiority of tirzepatide to ...
In its first evidence-based clinical practice guidelines, the European Association for the Study of Diabetes advises clinicians to inquire about ...
(MedPage Today) -- Tirzepatide (Mounjaro) improved glucose control and body mass index (BMI) in children with type 2 diabetes who ...
(MedPage Today) -- House members seemed generally supportive Thursday of bills that would expand access to "breakthrough" medical devices, although ...
(MedPage Today) -- TORONTO -- A three-drug combination involving the B-cell maturation antigen (BCMA)-CD3 bispecific antibody elranatamab (Elrexfio) was associated ...
Declines in oestrogen during menopause may have cognitive effectsElena Popova/Getty Images Beginning hormone replacement therapy (HRT) within five years of ...
(MedPage Today) -- Republican Texas Gov. Greg Abbott has signed a first-of-its-kind law that lets anyone sue prescribers and others ...
© 2022 NewsHealth.
© 2022 NewsHealth.